4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-25-000283
Director sold 3,948 shares at $55.17 ($217,811)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Collins Richard Alexander Director | 2025-11-10 | Sale 10b5-1 | −3,948 | $55.17 | $217,811 | 37,994 | I: show line 1 in the form |
| Open-market sales · 3,948 sh · avg $55.17 · $217,811 | |||||||
Loading xslF345X05/wk-form4_1762819958.xml…